Profile data is unavailable for this security.
About the company
Synairgen plc is a United Kingdom-based holding company for Synairgen Research Limited, which is a respiratory drug discovery and development company. The Company is developing SNG001, an investigative formulation of inhaled interferon beta (IFN-B), for the treatment and prevention of various viral lung infections in high-risk patient groups. The Company has developed and is testing an inhaled formulation of IFN-B designed to directly target the lungs, the primary site of many viral lung infections, including COVID-19.
- Revenue in GBP (TTM)0.00
- Net income in GBP-8.41m
- Incorporated2004
- Employees36.00
- LocationSynairgen PLCSouthampton General Hosp, Tremona RoadSOUTHAMPTON SO16 6YDUnited KingdomGBR
- Phone+44 238 051 2800
- Fax+44 238 051 2800
- Websitehttps://www.synairgen.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ValiRx Plc | 9.60k | -2.04m | 2.18m | 8.00 | -- | 0.5245 | -- | 227.47 | -0.0201 | -0.0201 | 0.00009 | 0.0315 | 0.0027 | -- | 0.0682 | -- | -59.88 | -50.57 | -58.27 | -54.77 | 85.00 | -- | -22,164.48 | -103,908.50 | 2.32 | -520.03 | 0.0075 | -- | -- | -- | 13.89 | -- | -1.13 | -- |
Fusion Antibodies PLC | 1.14m | -2.23m | 3.10m | 31.00 | -- | 1.73 | -- | 2.73 | -0.0426 | -0.0426 | 0.0205 | 0.0188 | 0.5069 | 2.36 | 2.02 | 36,645.16 | -99.33 | -41.50 | -147.47 | -52.23 | -3.96 | 40.19 | -195.95 | -56.92 | 3.09 | -1,144.00 | 0.0234 | -- | -60.84 | -12.24 | 14.25 | -- | -72.95 | -- |
TheraCryf PLC | 396.00k | -3.14m | 3.31m | 9.00 | -- | 0.91 | -- | 8.36 | -0.0114 | -0.0114 | 0.0014 | 0.0085 | 0.0858 | -- | 0.9766 | 44,000.00 | -67.93 | -42.50 | -81.69 | -46.66 | -- | -- | -792.17 | -1,482.46 | -- | -- | 0.00 | -- | -10.41 | -- | 22.41 | -- | -- | -- |
IXICO PLC | 6.00m | -1.87m | 4.59m | 89.00 | -- | 0.4576 | -- | 0.7656 | -0.0386 | -0.0386 | 0.1241 | 0.2076 | 0.4725 | -- | 3.54 | 67,415.73 | -14.69 | 4.35 | -16.58 | 5.33 | 46.90 | 62.09 | -31.10 | 6.61 | -- | -- | 0.0312 | 0.00 | -22.89 | 4.32 | -214.15 | -- | 92.12 | -- |
ImmuPharma PLC | -69.96k | -2.46m | 7.37m | 5.00 | -- | 2.74 | -- | -- | -0.0065 | -0.0065 | -0.0002 | 0.0065 | -0.019 | -- | -- | -13,992.00 | -66.99 | -86.13 | -111.20 | -106.39 | -- | -- | -- | -8,634.98 | -- | -7.27 | 0.00 | -- | -- | -- | 23.26 | -- | -- | -- |
Synairgen plc | 0.00 | -8.41m | 7.55m | 36.00 | -- | 0.5966 | -- | -- | -0.0418 | -0.0418 | 0.00 | 0.0629 | 0.00 | -- | -- | 0.00 | -44.55 | -54.01 | -51.06 | -60.02 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 52.35 | -- | -26.64 | -- |
Genflow Biosciences PLC | 0.00 | -1.63m | 7.61m | 5.00 | -- | 8.76 | -- | -- | -0.0056 | -0.0056 | 0.00 | 0.0025 | 0.00 | -- | -- | 0.00 | -88.30 | -- | -105.34 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -21.97 | -- | -- | -- |
Cizzle Biotechnology Holdings PLC | 0.00 | -1.72m | 7.93m | 67.00 | -- | 4.83 | -- | -- | -0.0048 | -0.0048 | 0.00 | 0.0041 | 0.00 | -- | -- | -- | -76.69 | -144.15 | -82.81 | -167.75 | -- | -- | -- | -- | -- | -0.805 | 0.00 | -- | -- | -- | -88.27 | -- | -- | -- |
LungLife AI Inc | 21.77k | -3.35m | 8.25m | 15.00 | -- | 0.5121 | -- | 379.18 | -0.126 | -0.126 | 0.0008 | 0.2337 | 0.0027 | -- | 2.90 | 1,451.33 | -42.18 | -- | -47.78 | -- | 100.00 | -- | -15,403.45 | -- | -- | -- | 0.0259 | -- | 91.67 | -- | 28.83 | -- | -- | -- |
Oxford Biodynamics PLC | 617.00k | -11.11m | 11.73m | 45.00 | -- | 4.69 | -- | 19.00 | -0.0643 | -0.0643 | 0.0035 | 0.008 | 0.0487 | 1.20 | 0.379 | 13,711.11 | -87.64 | -39.72 | -114.28 | -45.52 | 41.49 | -- | -1,800.32 | -1,324.62 | 0.6156 | -87.72 | 0.7873 | -- | 231.17 | -15.53 | -61.34 | -- | -1.60 | -- |
OptiBiotix Health PLC | 644.00k | -2.04m | 16.90m | 5.00 | -- | 1.77 | -- | 26.23 | -0.023 | -0.023 | 0.0071 | 0.0973 | 0.0615 | 1.77 | 1.31 | 128,800.00 | -19.46 | 16.82 | -19.90 | 17.52 | 49.69 | 53.03 | -316.61 | 183.49 | 6.62 | -4.87 | 0.00 | 100.14 | 40.92 | 4.60 | -178.82 | -- | -- | -- |
Hemogenyx Pharmaceuticals PLC | 0.00 | -6.69m | 19.78m | 17.00 | -- | 6.15 | -- | -- | -0.0061 | -0.0061 | 0.00 | 0.0024 | 0.00 | -- | -- | 0.00 | -101.47 | -82.19 | -112.85 | -95.97 | -- | -- | -- | -- | -- | -28.03 | 0.5144 | -- | -- | -- | -68.14 | -- | 36.68 | -- |
Data as of Sep 23 2024. Currency figures normalised to Synairgen PLC's reporting currency: UK Pound GBX
Holder | Shares | % Held |
---|---|---|
TFG Asset Management UK LLPas of 26 Apr 2023 | 56.70m | 28.15% |
Link Fund Solutions Ltd.as of 30 Jun 2019 | 21.34m | 10.60% |
Data from 31 Mar 2024 - 30 Apr 2024Source: FactSet Research Systems Inc.